10 Sep 2015 15:11
10 September 2015
Consort Medical plc
Notification of Transactions of Directors or
Persons Discharging Managerial Responsibility and Connected Persons
DTR 3.1.4
On 10 September 2015, following the approval by shareholders of the Consort Medical plc Performance Share Plan 2015 ('PSP') at the Annual General Meeting held on 3 September 2015 and pursuant to the terms of the PSP, the following Directors/persons discharging managerial responsibilities ("PDMRs") of Consort Medical plc (the "Company"), were granted awards over ordinary shares in the Company ("Shares").
Director/PDMR | Number of Shares |
Jonathan Glenn | 49,308 |
Richard Cotton | 32,043 |
Each of the awards was granted as a nil cost option, in replacement for, in respect of the same number of Shares and subject to the same vesting period and performance targets as the awards granted to the Directors on 19 June 2015 under the 2005 Long Term Incentive Plan ('LTIP') which awards have now lapsed following the grant of the new awards under the PSP.
Enquiries: I Ward 01442 867920
Consort Medical plc is a leading, global, single source drug and delivery device CDMO through its two operating subsidiaries Bespak and Aesica. Consort Medical is at the leading edge of innovation and is committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.
Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectables products, and the manufacture of devices for the point of care diagnostics market.
Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners.
The Group has facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Nottingham, Queenborough and Hemel Hempstead, UK; in Monheim and Zwickau, Germany; and in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). The Group's website address is www.consortmedical.com.